260 related articles for article (PubMed ID: 20212212)
1. Bilateral superselective ophthalmic artery chemotherapy for bilateral retinoblastoma: tandem therapy.
Abramson DH; Dunkel IJ; Brodie SE; Marr B; Gobin YP
Arch Ophthalmol; 2010 Mar; 128(3):370-2. PubMed ID: 20212212
[No Abstract] [Full Text] [Related]
2. Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery).
Abramson DH; Dunkel IJ; Brodie SE; Marr B; Gobin YP
Ophthalmology; 2010 Aug; 117(8):1623-9. PubMed ID: 20381868
[TBL] [Abstract][Full Text] [Related]
3. Ophthalmic artery chemosurgery for eyes with advanced retinoblastoma.
Abramson DH; Fabius AW; Francis JH; Marr BP; Dunkel IJ; Brodie SE; Escuder A; Gobin YP
Ophthalmic Genet; 2017; 38(1):16-21. PubMed ID: 28095092
[TBL] [Abstract][Full Text] [Related]
4. Intra-arterial chemotherapy for retinoblastoma in 70 eyes: outcomes based on the international classification of retinoblastoma.
Shields CL; Manjandavida FP; Lally SE; Pieretti G; Arepalli SA; Caywood EH; Jabbour P; Shields JA
Ophthalmology; 2014 Jul; 121(7):1453-60. PubMed ID: 24656794
[TBL] [Abstract][Full Text] [Related]
5. Retinal vascular precipitates during administration of melphalan into the ophthalmic artery.
Superstein R; Lederer D; Dubois J; Hamel P; Carret AS; Callejo S
JAMA Ophthalmol; 2013 Jul; 131(7):963-5. PubMed ID: 23846208
[No Abstract] [Full Text] [Related]
6. Visual outcomes following intraophthalmic artery melphalan for patients with refractory retinoblastoma and age appropriate vision.
Tsimpida M; Thompson DA; Liasis A; Smith V; Kingston JE; Sagoo MS; Reddy MA
Br J Ophthalmol; 2013 Nov; 97(11):1464-70. PubMed ID: 24037611
[TBL] [Abstract][Full Text] [Related]
7. Clinical pharmacokinetics of intra-arterial melphalan and topotecan combination in patients with retinoblastoma.
Taich P; Ceciliano A; Buitrago E; Sampor C; Fandino A; Villasante F; Lucena E; Romero L; Chantada GL; Schaiquevich P
Ophthalmology; 2014 Apr; 121(4):889-97. PubMed ID: 24359624
[TBL] [Abstract][Full Text] [Related]
8. Selective Ophthalmic Artery Infusion Chemotherapy for Advanced Intraocular Retinoblastoma: CCHMC Early Experience.
Michaels ST; Abruzzo TA; Augsburger JJ; Corrêa ZM; Lane A; Geller JI
J Pediatr Hematol Oncol; 2016 Jan; 38(1):65-9. PubMed ID: 26583615
[TBL] [Abstract][Full Text] [Related]
9. Rescue intra-arterial chemotherapy following retinoblastoma recurrence after initial intra-arterial chemotherapy.
Shields CL; Say EA; Pointdujour-Lim R; Cao C; Jabbour PM; Shields JA
J Fr Ophtalmol; 2015 Jun; 38(6):542-9. PubMed ID: 25982423
[TBL] [Abstract][Full Text] [Related]
10. Real-time ophthalmoscopic findings of intraophthalmic artery chemotherapy in retinoblastoma.
Fallaha N; Dubois J; Carret AS; Callejo SA; Hamel P; Superstein R
Arch Ophthalmol; 2012 Aug; 130(8):1075-7. PubMed ID: 22893086
[No Abstract] [Full Text] [Related]
11. Globe Salvage With Intra-Arterial Topotecan-Melphalan Chemotherapy in Children With a Single Eye.
Leal-Leal CA; Asencio-López L; Higuera-Calleja J; Bernal-Moreno M; Bosch-Canto V; Chávez-Pacheco J; Isaac-Otero G; Beck-Popovic M
Rev Invest Clin; 2016; 68(3):137-42. PubMed ID: 27409000
[TBL] [Abstract][Full Text] [Related]
12. Fluorescein angiographic findings after intra-arterial chemotherapy for retinoblastoma.
Bianciotto C; Shields CL; Iturralde JC; Sarici A; Jabbour P; Shields JA
Ophthalmology; 2012 Apr; 119(4):843-9. PubMed ID: 22137042
[TBL] [Abstract][Full Text] [Related]
13. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results.
Abramson DH; Dunkel IJ; Brodie SE; Kim JW; Gobin YP
Ophthalmology; 2008 Aug; 115(8):1398-404, 1404.e1. PubMed ID: 18342944
[TBL] [Abstract][Full Text] [Related]
14. Total retinal detachments due to retinoblastoma: Outcomes following intra-arterial chemotherapy/ophthalmic artery chemosurgery.
Rowlands MA; Mondesire-Crump I; Levin A; Mauguen A; Francis JH; Dunkel IJ; Brodie SE; Gobin YP; Abramson DH
PLoS One; 2018; 13(4):e0195395. PubMed ID: 29698399
[TBL] [Abstract][Full Text] [Related]
15. Persistence of retinal function after selective ophthalmic artery chemotherapy infusion for retinoblastoma.
Brodie SE; Pierre Gobin Y; Dunkel IJ; Kim JW; Abramson DH
Doc Ophthalmol; 2009 Aug; 119(1):13-22. PubMed ID: 19169884
[TBL] [Abstract][Full Text] [Related]
16. Retinoblastoma Vitreous Seed Clouds (Class 3): A Comparison of Treatment with Ophthalmic Artery Chemosurgery with or without Intravitreous and Periocular Chemotherapy.
Francis JH; Iyer S; Gobin YP; Brodie SE; Abramson DH
Ophthalmology; 2017 Oct; 124(10):1548-1555. PubMed ID: 28545735
[TBL] [Abstract][Full Text] [Related]
17. Superselective ophthalmic artery infusion of melphalan for intraocular retinoblastoma: preliminary results from 140 treatments.
Venturi C; Bracco S; Cerase A; Cioni S; Galluzzi P; Gennari P; Vallone IM; Tinturini R; Vittori C; De Francesco S; Caini M; D'Ambrosio A; Toti P; Renieri A; Hadjistilianou T
Acta Ophthalmol; 2013 Jun; 91(4):335-42. PubMed ID: 22268993
[TBL] [Abstract][Full Text] [Related]
18. Intra-arterial chemotherapy is more effective than sequential periocular and intravenous chemotherapy as salvage treatment for relapsed retinoblastoma.
Schaiquevich P; Ceciliano A; Millan N; Taich P; Villasante F; Fandino AC; Dominguez J; Chantada GL
Pediatr Blood Cancer; 2013 May; 60(5):766-70. PubMed ID: 23024125
[TBL] [Abstract][Full Text] [Related]
19. Complete regression of retinoblastoma following intra-arterial chemotherapy.
Ni N; Shields CL; Bianciotto CG; Jabbour PM; Rosenwasser RH; Shields JA
J Pediatr Ophthalmol Strabismus; 2011 Jun; 48 Online():e23-5. PubMed ID: 21634361
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic analysis of melphalan after superselective ophthalmic artery infusion in preclinical models and retinoblastoma patients.
Schaiquevich P; Buitrago E; Taich P; Torbidoni A; Ceciliano A; Fandino A; Asprea M; Requejo F; Abramson DH; Bramuglia GF; Chantada GL
Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):4205-12. PubMed ID: 22628208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
